ProMIS Neurosciences EPS
Was ist das EPS von ProMIS Neurosciences?
EPS von ProMIS Neurosciences, Inc. ist -0.02
Was ist die Definition von EPS?
Der Gewinn pro Aktie (EPS) ist der Anteil des Gewinns eines Unternehmens, der jeder im Umlauf befindlichen Stammaktie zugewiesen wird. Es wird der Verdünnung angepasst und über letzten zwölf Monate nachgerechnet.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS von Unternehmen in Health Care Sektor auf OTC im Vergleich zu ProMIS Neurosciences
Was macht ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Unternehmen mit eps ähnlich ProMIS Neurosciences
- China Fordoo hat EPS von -0.02
- The Supreme Cannabis Co hat EPS von -0.02
- Peijia Med Ltd hat EPS von -0.02
- Milan Station hat EPS von -0.02
- Imperial Metals hat EPS von -0.02
- Newcastle hat EPS von -0.02
- ProMIS Neurosciences hat EPS von -0.02
- Platina Resources hat EPS von -0.02
- Lvji Technology Inc hat EPS von -0.02
- good natured Products hat EPS von -0.02
- Wan Leader International hat EPS von -0.02
- Sarama Resources Ltd hat EPS von -0.02
- Grand Ming hat EPS von -0.02